Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-09-30 21:22:33 - browse：9

After physically debilitating cancer treatment, Laurie Brunner encountered another medical hurdle: She had developed lymphedema that required surgery, but her BMI was over the cutoff. To receive the necessary treatment, she would have to lose weight.

“But after everything I’ve been through, my body was just not having it,” she said. So she turned to Jody Dushay, an endocrinologist at the Beth Israel Deaconess Medical Center and assistant professor of medicine at Harvard Medical School. After much discussion, the two decided that Laurie should try using weight loss medication — specifically, Wegovy — so she could become eligible for the surgery.

Before long, they had to grapple with the shortage of GLP-1 medications. “Within the first two months she had a good response,” Jody said. But “then there was the first round of shortages. … It looks like, you know, we’re heading towards that finish line. And then, ‘Oh, sorry, you can’t get it anymore.’”

On the “First Opinion Podcast,” I spoke with Jody and Laurie about how the ongoing shortages of GLP-1 medications are creating logistical and medical problems. Our conversation was based on Jody’s recent First Opinion essay, “How the Wegovy shortage is making life impossible for my patients — and for me.” We talked about the patient and provider perspective, the way stigma affects access to care, the ways weight loss medications are changing the medical system, and how the drug shortage is only part of the problem of access.

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts.

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： After sickle

explore

WSS

ACA's risk program benefits Blue Cross Blue Shield insurers

The U.S. needs a new definition of substance use “recovery”

Recent heat wave in the Mediterranean caused by climate change: Study

STAT Event – Decoding Clinical Trials: Venture Capitalists Talk Early Biotech R&D

Pfizer plans to depart BIO

‘Insidious 5’ topples 'Indiana Jones' before ‘Mission: Impossible’ launches

knowledge

Wikipedia

hotspot

Wildfire smoke exposes gaps in outdoor worker protections

Chemotherapy shortages won’t get better under Biden’s latest plan

23andMe had bad news about my health. I wish a person had delivered it

Pregnancy discrimination could be enabled by AI

Jerome Adams on the need for new antivirals for Covid

Parents surprise family after baby discharged from NICU after 170 days

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

explore

ACA's risk program benefits Blue Cross Blue Shield insurers

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

SCOTUS to consider access to abortion pill mifepristone

Despite FDA approval for Lyfgenia, Bluebird faces stiff competition

Pharma patents targeted by Biden in move to slash drug prices

Tulsa Race Massacre survivors and attorneys respond to dismissal of lawsuit

explore

leisure time

hotspot

explore